What is lifecycle evidence generation?
Lifecycle evidence generation refers to the continuous and coordinated production of data to support a pharmaceutical product across its entire lifespan. This includes clinical trials, real-world studies, health economic analyses, and post-marketing research. Each stage is designed to address evolving regulatory, payer, and clinical needs.
Why is lifecycle evidence generation important in pharmaceutical development?
Stakeholder expectations change over time, requiring ongoing evidence to support access, reimbursement, and clinical adoption. A lifecycle approach ensures data remains relevant, timely, and aligned with market dynamics. It also supports long-term product differentiation and sustained value communication.
